The Femtech market, encompassing technology-driven solutions for women's health, has witnessed significant growth in recent years. With advancements in digital health, increased awareness, and a focus on personalized care, Femtech is reshaping the landscape of women's healthcare.
In 2023, the global femtech market size was valued at USD 6.69 billion. It is expected to grow from USD 7.75 billion in 2024 to USD 29.62 billion by 2032, registering a robust compound annual growth rate (CAGR) of 18.2% during the forecast period (2024–2032). North America led the market in 2023, capturing a dominant share of 52.91%.
In January 2024, Natural Cycles received Health Canada’s approval to commercialize its Natural Cycles app as a form of birth control, marking a significant milestone in digital contraceptive solutions.